Valuation: Zenotech Laboratories Limited

Market Cap 2.63B 27.69M 24.61M 22.81M 20.76M 39.17M 39.8M 274M 108M 1.37B 104M 102M 4.37B P/E 2025
56.5x
P/E 2026 -191x
Enterprise Value 2.32B 24.48M 21.76M 20.17M 18.35M 34.63M 35.19M 242M 95.07M 1.21B 91.89M 89.93M 3.87B EV / Sales 2025
7.42x
EV / Sales 2026 4.45x
Free-Float
15.47%
Yield 2025 *
-
Yield 2026 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day-2.03%
1 week-0.02%
Current month+2.94%
1 month-2.91%
3 months-9.48%
6 months-10.35%
Current year-6.78%
1 week 41.5
Extreme 41.5
44.25
1 month 41
Extreme 41
46
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
54.14
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 22/10/2024
Director of Finance/CFO - 05/02/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 59 07/07/2015
Chairman 68 -
Director/Board Member 53 31/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.03%-0.02%-14.58%-42.36% 27.69M
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.36%+3.25%+30.19%+51.25% 394.09B
Weighted average by Cap. +0.13%+3.83%+39.18%+71.44%

Financials

2025 2026
Net sales 391M 4.12M 3.66M 3.39M 3.09M 5.83M 5.92M 40.8M 16M 204M 15.46M 15.13M 650M 402M 4.23M 3.76M 3.49M 3.17M 5.99M 6.08M 41.91M 16.43M 210M 15.88M 15.54M 668M
Net income 56.13M 591K 526K 487K 443K 837K 850K 5.86M 2.3M 29.29M 2.22M 2.17M 93.37M -10.72M -113K -100K -93.07K -84.68K -160K -162K -1.12M -439K -5.59M -424K -415K -17.83M
Net Debt -267M -2.81M -2.5M -2.32M -2.11M -3.98M -4.04M -27.87M -10.93M -139M -10.56M -10.34M -444M -304M -3.21M -2.85M -2.64M -2.4M -4.53M -4.61M -31.75M -12.45M -159M -12.03M -11.77M -506M
Projected Income Statement - Annual - Zenotech Laboratories Limited
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
264
Date Price Change Volume
16/10/26 ₹43.06 -2.03% 1,174
15/10/26 ₹43.95 +1.03% 7,862
14/10/26 ₹43.50 -0.37% 2,543
13/10/26 ₹43.66 +3.34% 4,093
12/10/26 ₹42.25 -1.90% 4,170
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock